Alzamend Neuro (ALZN)Director sold ~$69

~$69

Approx. value · 30 sh @ $2.29

25

Holds after · shares reported

Traded

Oct 23, 2025

Filed

Oct 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 17, 2025InsiderDirector sold ~$5.2K of ALZN shares in the open market
2. Sep 18, 2025InsiderDirector sold ~$51K of ALZN shares in the open market
3. Sep 19, 2025InsiderDirector sold ~$181K of ALZN shares in the open market
4. Sep 23, 2025InsiderDirector sold ~$103K of ALZN shares in the open market
5. Sep 24, 2025InsiderDirector sold ~$90K of ALZN shares in the open market
6. Sep 25, 2025Company filing · Form 8-K · Unregistered sharesSold new shares without registering them
7. Sep 25, 2025InsiderDirector sold ~$34K of ALZN shares in the open market
8. Sep 26, 2025InsiderDirector sold ~$87K of ALZN shares in the open market
9. Sep 29, 2025InsiderDirector sold ~$88K of ALZN shares in the open market
10. Sep 30, 2025InsiderDirector sold ~$8.3K of ALZN shares in the open market
11. Oct 6, 2025InsiderDirector sold ~$201K of ALZN shares in the open market
12. Oct 7, 2025InsiderDirector sold ~$143K of ALZN shares in the open market
13. Oct 8, 2025InsiderDirector sold ~$247K of ALZN shares in the open market
14. Oct 9, 2025Company filing · Form 8-K · Unregistered sharesSold new shares without registering them
15. Oct 9, 2025InsiderDirector sold ~$47K of ALZN shares in the open market
16. Oct 14, 2025Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
17. Oct 23, 2025 · this disclosureInsiderDirector sold ~$69 of ALZN shares in the open market

What came next

1. Dec 19, 2025InsiderDirector sold ~$7.1K of ALZN shares in the open market
2. Dec 23, 2025InsiderDirector sold ~$3.8K of ALZN shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alzamend Neuro

For Alzamend Neuro, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALZN page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Alzamend Neuro

• SEC Form 4Aug 31, 2026
• SEC Form 4Aug 31, 2026
• SEC Form 4Aug 31, 2026
• SEC Form 4Dec 30, 2025
• SEC Form 4Dec 23, 2025
• SEC Form 4Oct 10, 2025

Everything OQRO holds on this company is on its ALZN page.